<DOC>
	<DOC>NCT00454233</DOC>
	<brief_summary>The purpose of this study is to investigate the safety of YM543 in type 2 Diabetes Mellitus patients and to investigate whether this study drug is effective in these patients</brief_summary>
	<brief_title>A Safety and Efficacy Study With YM543 in Type 2 Diabetes Mellitus Subjects</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<criteria>Treatmentnaive subjects diagnosed with T2DM Stable diet and exercise program for at least 6 weeks Inadequate glycemic control indicated by HbA1c and FPG level at Visit 1 Any known complication of T2DM indicating a late disease state, clinical manifestations of macro and/or micro vascular disorders Use of insulin or oral blood glucose lowering drugs in the last 3 months</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>Diabetes Mellitus Type 2</keyword>
	<keyword>YM543</keyword>
	<keyword>Treatment</keyword>
	<keyword>Safety</keyword>
	<keyword>efficacy</keyword>
</DOC>